HGF, Eotaxin/CCL11, MCP-1/CCL2, Rantes/CCL5, EGF and MIP-1β/CCL4 comparison in the test and validation cohorts.
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://figshare.com/articles/dataset/_HGF_Eotaxin_CCL11_MCP_1_CCL2_Rantes_CCL5_EGF_and_MIP_1_946_CCL4_comparison_in_the_test_and_validation_cohorts_/1435493
下载链接
链接失效反馈官方服务：
资源简介：
Mann—Whitney statistical test was used for calculation of the reported p-value between RR-MS vs Progressive MS; RR-MS = Relapsing-Remitting MS patients. Note that the Relapsing-remitting group comprises the clinical groups: RR-MS Remission, RR-MS Active, RESPONDERS, NON RESPONDERS and RELAPSES. The Progressive group comprises Secondary (SP-MS) and Primary-progressive patients.
Results are given as Median value (IQR1–3). Statistical significance is marked as:
*p<0.05;
**p<0.01;
***p<0.001.
# p = 0.06 (trend).
HGF, Eotaxin/CCL11, MCP-1/CCL2, Rantes/CCL5, EGF and MIP-1β/CCL4 comparison in the test and validation cohorts.
创建时间：
2015-12-03
